References
- Amaral, P.P., et al., 2008. The eukaryotic genome as an RNA machine. Science, 319 (5871), 1787–1789.
- Booton, R., and Lindsay, M.A., 2014. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest, 146 (1), 193–204.
- Cáceres-Durán, M., Ribeiro-Dos-Santos, Â., and Vidal, A.F., 2020. Roles and mechanisms of the long noncoding RNAs in cervical cancer. International journal of molecular sciences, 21 (24), 9742.
- Cao, Z., et al., 2022. The roles of long non-coding RNAs in lung cancer. Journal of cancer, 13 (1), 174–183.
- Chen, L., et al., 2021. Role and mechanism of exosome-derived long noncoding RNA HOTAIR in lung cancer. ACS omega, 6 (27), 17217–17227.
- Chen, Y., et al., 2021. Long non-coding RNAs: From disease code to drug role. Acta pharmaceutica sinica. B, 11 (2), 340–354.
- Chheang, S., and Brown, K., 2013. Lung cancer staging: clinical and radiologic perspectives. Seminars in interventional radiology, 30 (02), 099–113. Thieme Medical Publishers,
- Ebahimzadeh, K., et al., 2021. Emerging role of non-coding RNAs in response of cancer cells to radiotherapy. Pathology, research and practice, 218, 153327.
- Enfield, K.S., et al., 2012. Mechanistic roles of noncoding RNAs in lung cancer biology and their clinical implications. Genetics research international, 2012, 737416.
- Ferlay, J., et al., 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer, 136 (5), E359–E86.
- Guo, F., et al., 2018. The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. Experimental and therapeutic medicine, 15, 4885–4889.
- Guo, Y.P., et al., 2021. Suppression of lncRNA HOTAIR alleviates RCC angiogenesis through regulating miR-126/EGFL7 axis. American journal of physiology. Cell physiology, 320 (5), C880–c91.
- Huang, H., Wang, J., and Liu, F., 2021. Phenotypic Changes of LncRNA Hotair in Non-Small-Cell Lung Cancer and Its Clinical Application. Journal of healthcare engineering, 2021 (3215143), 3215143.
- Izzotti, A., and Pulliero, A., 2014. The effects of environmental chemical carcinogens on the microRNA machinery. International journal of hygiene and environmental health, 217 (6), 601–627.
- Kim, I.J., et al., 2021. Association between HOTAIR lncRNA polymorphisms and coronary artery disease susceptibility. Journal of personalized medicine, 11 (56), 375.
- Li, H., et al., 2020. Long noncoding RNA EBLN3P promotes the progression of liver cancer via alteration of microRNA-144-3p/DOCK4 Signal. Cancer management and research, 12, 9339–9349.
- Li, H., et al., 2020. Long non-coding RNA HOTAIR function as a competing endogenous RNA for miR-149-5p to promote the cell growth, migration, and invasion in non-small. Frontiers in oncology, 10 (528520), 528520.
- Li, H., et al., 2021. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas. Annals of diagnostic pathology, 55, 151801.
- Li, W., et al., 2021. HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. Journal of cancer, 12 (18), 5562–5572.
- Li, H.S., and Xu, Y., 2020. Inhibition of EZH2 via the STAT3/HOTAIR signalling axis contributes to cell cycle arrest and apoptosis induced by polyphyllin I in human non-small cell lung cancer cells. Steroids, 164, 108729.
- Liu, B., et al., 2019. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade. Journal of experimental & clinical cancer research: CR, 38 (1), 455.
- Liu, M., et al., 2018. HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer. Cancer science, 109 (9), 2717–2733.
- Liu, X-h., et al., 2013. The long non-coding RNA HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer. BMC cancer, 13 (1), 10.
- Mahpour, A., and Mullen, A.C., 2021. Our emerging understanding of the roles of long non-coding RNAs in normal liver function, disease, and malignancy. JHEP reports: innovation in hepatology, 3 (1), 100177.
- Maruyama, R., and Yokota, T., 2020. Knocking down long noncoding RNAs using antisense oligonucleotide gapmers. Methods in molecular biology, 2176, 49–56.
- Minn, A.K.K., et al., 2020. Association study of long non-coding RNA HOTAIR rs920778 polymorphism with the risk of cancer in an elderly Japanese population. Gene, 729, 144263.
- Ono, H., et al., 2014. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer . Cancer medicine, 3 (3), 632–642.
- Puglisi, M., et al., 2010. Treatment options for small cell lung cancer - do we have more choice? British journal of cancer, 102 (4), 629–638.
- Ren, M.M., et al., 2020. Roles of HOTAIR in lung cancer susceptibility and prognosis. Molecular genetics & genomic medicine, 8 (7), e1299.
- Roointan, A., et al., 2019. Early detection of lung cancer biomarkers through biosensor technology: A review. Journal of pharmaceutical and biomedical analysis, 164, 93–103.
- Sassenberg, M., et al., 2019. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. BMC cancer, 19 (1), 806.
- Sun, X., and Chen, Z., 2021. Cancer-associated fibroblast-derived CCL5 contributes to cisplatin resistance in A549 NSCLC cells partially through upregulation of lncRNA HOTAIR expression. Oncology letters, 22 (4), 696.
- Sun, Y.J., Li, J., and Chen, C.H., 2019. Effects of miR-221 on the apoptosis of non-small cell lung cancer cells by lncRNA HOTAIR. European review for medical and pharmacological sciences, 23, 4226–4233.
- Tokgun, O., et al., 2020. lncRNAs as potential targets in small cell lung cancer: MYC-dependent Regulation. Anti-cancer agents in medicinal chemistry, 20 (17), 2074–2081.
- Vansteenkiste, J., et al., 2013. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 24, vi89–vi98.
- Wang, Q., et al., 2020. HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition. Lung cancer, 147, 99–105.
- Wang, X., et al., 2019. The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer. Journal of thoracic disease, 11 (5), 1772–1778.
- Xu, G., et al., 2014. Long noncoding RNA expression profiles of lung adenocarcinoma ascertained by microarray analysis. PLoS One, 9 (8), e104044.
- Yang, J., et al., 2014. Analysis of lncRNA expression profiles in non-small cell lung cancers (NSCLC) and their clinical subtypes. Lung cancer, 85 (2), 110–115.
- Yu, Y., and Ren, K., 2021. Five long non-coding RNAs establish a prognostic nomogram and construct a competing endogenous RNA network in the progression of non-small cell lung cancer. BMC cancer, 21 (1), 457.
- Zequn, N., et al., 2016. The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer. Oncotarget, 7 (14), 18219–18228.
- Zhai, Y., et al., 2020. Down-regulation of HOTAIR Reverses the Resistance of Gefitinib in HCC827 Cells by Increasing the Expression of PTEN. Zhongguo Fei Ai za Zhi, 23, 762–771.
- Zhan, Y., et al., 2020. Knockdown of long non-coding RNA HOTAIR suppresses cisplatin resistance, cell proliferation, migration and invasion of DDP-resistant NSCLC cells by targeting miR-149-5p/Doublecortin-like kinase 1 axis. Cancer management and research, 12, 7725–7737.
- Zhang, C., et al., 2020. Exosomal HOTAIR promotes proliferation, migration and invasion of lung cancer by sponging miR-203. Science China. Life sciences, 63 (8), 1265–1268.
- Zhao, W.H., Yuan, H.Y., et al., 2019. Association between expression of HOTAIR and invasiveness of gliomas, and its predictive value. Advances in clinical and experimental medicine, 28 (9), 1179–1183.
- Zheng, F., et al., 2020. Novel regulation of miR-34a-5p and HOTAIR by the combination of berberine and gefitinib leading to inhibition of EMT in human lung cancer. Journal of cellular and molecular medicine, 24 (10), 5578–5592.